Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study

Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study

Abstract Background High rates of postoperative tumor recurrence contribute to poor outcome in hepatocellular carcinoma (HCC). Here, we investigated whether circulating tumor cells (CTCs) status can predict the benefit of adjuvant transcatheter arterial chemoembolization (TACE) in patients with HCC....

Full description

Bibliographic Details
Main Authors: Peng‐Xiang Wang, Yun‐Fan Sun, Kai‐Qian Zhou, Jian‐Wen Cheng, Bo Hu, Wei Guo, Yue Yin, Jun‐Feng Huang, Jian Zhou, Jia Fan, Tan To Cheung, Xu‐Dong Qu, Xin‐Rong Yang
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Clinical and Translational Medicine
Subjects:
a propensity score matching analysis
adjuvant transcatheter arterial chemoembolization
circulating tumor cells
hepatocellular carcinoma
Online Access:https://doi.org/10.1002/ctm2.137

Internet

https://doi.org/10.1002/ctm2.137

Similar Items